Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR Study

Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Study ID
NCT06071520
Status
Completed

Conditions

  • Primary Immune Thrombocytopenia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Fostamatinib — DRUG
    Patient treated with fostamatinib in the period described

Study Details

Description of the use of fostamatinib in patients with PTI in the Andalusian region.

Key Dates

Start date
Mar 1, 2023
Status verified
Oct 2023
Primary completion
Apr 1, 2023
Completion
Jun 30, 2023

Study Design

Enrollment
50 participants (actual)

Arms

  • Arm: PTI patients treated with fostamatinib
    Patient with criteria of PTI who has been treated with fostamatinib in the time described

Primary Outcome Measure

Description of fostamatinib use [ Time Frame: From fostamatinib prescription first date ]

Related Studies